Figure 1

Figure 2
![Sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more (CIN2+) by test (cytology, human papillomaviruses [HPV]), testing modality (self, clinician) and self-sampling device (Qvintip, HerSwab) after four years of follow-up following enrolment.ASC-US+ = atypical squamous cells of undetermined significance or more](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355f34e662f30ba53aa8d/j_raon-2021-0001_fig_002.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKHL7ER5IB%2F20260118%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260118T230720Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELr%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaDGV1LWNlbnRyYWwtMSJIMEYCIQDC540x9zF5aKgFDkSOTwbNpMYOXiye5VRS7sidCU0pHwIhAOdxiOEosvc5T0HYReevkcSOplr6XzcH0bmrSn%2FvnXdrKsQFCIP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQAhoMOTYzMTM0Mjg5OTQwIgwdG676drOKiFdy6a0qmAXLSTY55Ak%2Fi7hrp4ayB1LqxXR1sFb%2FyQuLvrb57IDxZIjqJAfKdxn9RSJyR3A6RXO5kJjtGaDxFdX2VsW8Oc4c1y7hosd6fo6%2Bn1hA4bkZ4382daqSR6k85XVgomJ1t3ak4IWZU7U3YNyDPiwolvqyqvEq9gAgOYWbjes9th2gl6aTl%2F9rw8bs1npEKgkrO71KNKVj5aLBEQrB1uYbjQ3FHShVCxKNcrq7acyBN9Rir1eCqifX87oJFyG85KW4Js7mJdTMAcaVdxM4I7Cq1Ow1J3cCAUKSn41Zi%2FfjgHJRUN8p8HMqbCXnKnfNVbupAemqLlWHh5RaV3OF6eHb1%2FkkJrA5rS5DMB7J1bJrS7l%2BLU0SSgc48sc7tssNib%2FpOIiKLoyyGqnKnEscSe%2FbWQyde%2FAQ%2F%2FmLlvdu%2BeCj5CwSenz%2Ffbyv9ZCas5T5Jl9LNP7MPp5XNnimBSn1w190v9rqKhtm%2BnQl0werPBZija7w13%2F%2FtY6IVzb%2BBB2T4HI7TYSHk1jnHU4gQbnVJRJnfZxn2v7Xlq79e2UKSGTJrgZlMssK4Y86UzV6Xv%2BpnBY%2BsWS%2FxHhqFkejFmk1dUQ28dd0SQHRfZc%2BJ32jldaxiQGtAJjwt4PpDpVOMPMbsQrFH1%2BtbUZOUAiNUtz0K%2BBcMULKEVzCJ632CX497gXPZdg%2FCGEXTlix1JQZQIzwdE1GZRPiqn9dZ6319e%2B63uDYMCX2lBjMxKUmvW7qPR%2Bvk9cSxYYTXl7S2HgKM6ziBcVprmKXF5YQ8TE0BBKigV%2FEmb9T%2F%2BvYxmKcGOZ2iMe5dPC9GkmgGDc2Zaxjeh%2FsldIjhMywdgZAcaKgCk5zf6uys5EhO1zIKRBY225jOy9KHxCwpUeqx1NKsk0mMNO7tMsGOrAB3C2TMOREABZS%2BXnVNqLow5TsMAvKqicbqhHty5P31MiZi%2Fa8n0VSlCJAtFFwdfYyiqX60yfvu5%2FvoyOMJsH8aOK9VsLnxVNbyXQQyJryvsPax7hvKUthnXmhLSccACGHM27uvMMxcO%2BZvT0IjnaHpSxgceY0BJkP99A0ghuU730k8HwqtWOER9G2Yr2vFAqnqWmQjoU4MKKcfv2ZrSXGXKhszsyPoRY2YnUy0PvNwO4%3D&X-Amz-Signature=42415000fe35ca49558b39ec284c588c7a6def602d72d427514024fe646a87d0&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Figure 3
![Positive predictive value and negative predictive value for cervical intraepithelial neoplasia grade 2 or more (CIN2+) by test (cytology, human papillomaviruses [HPV]), testing modality (self, clinician) and self-sampling device (Qvintip, HerSwab).ASC-US+ = atypical squamous cells of undetermined significance or more](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355f34e662f30ba53aa8d/j_raon-2021-0001_fig_003.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKHL7ER5IB%2F20260118%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260118T230720Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELr%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaDGV1LWNlbnRyYWwtMSJIMEYCIQDC540x9zF5aKgFDkSOTwbNpMYOXiye5VRS7sidCU0pHwIhAOdxiOEosvc5T0HYReevkcSOplr6XzcH0bmrSn%2FvnXdrKsQFCIP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQAhoMOTYzMTM0Mjg5OTQwIgwdG676drOKiFdy6a0qmAXLSTY55Ak%2Fi7hrp4ayB1LqxXR1sFb%2FyQuLvrb57IDxZIjqJAfKdxn9RSJyR3A6RXO5kJjtGaDxFdX2VsW8Oc4c1y7hosd6fo6%2Bn1hA4bkZ4382daqSR6k85XVgomJ1t3ak4IWZU7U3YNyDPiwolvqyqvEq9gAgOYWbjes9th2gl6aTl%2F9rw8bs1npEKgkrO71KNKVj5aLBEQrB1uYbjQ3FHShVCxKNcrq7acyBN9Rir1eCqifX87oJFyG85KW4Js7mJdTMAcaVdxM4I7Cq1Ow1J3cCAUKSn41Zi%2FfjgHJRUN8p8HMqbCXnKnfNVbupAemqLlWHh5RaV3OF6eHb1%2FkkJrA5rS5DMB7J1bJrS7l%2BLU0SSgc48sc7tssNib%2FpOIiKLoyyGqnKnEscSe%2FbWQyde%2FAQ%2F%2FmLlvdu%2BeCj5CwSenz%2Ffbyv9ZCas5T5Jl9LNP7MPp5XNnimBSn1w190v9rqKhtm%2BnQl0werPBZija7w13%2F%2FtY6IVzb%2BBB2T4HI7TYSHk1jnHU4gQbnVJRJnfZxn2v7Xlq79e2UKSGTJrgZlMssK4Y86UzV6Xv%2BpnBY%2BsWS%2FxHhqFkejFmk1dUQ28dd0SQHRfZc%2BJ32jldaxiQGtAJjwt4PpDpVOMPMbsQrFH1%2BtbUZOUAiNUtz0K%2BBcMULKEVzCJ632CX497gXPZdg%2FCGEXTlix1JQZQIzwdE1GZRPiqn9dZ6319e%2B63uDYMCX2lBjMxKUmvW7qPR%2Bvk9cSxYYTXl7S2HgKM6ziBcVprmKXF5YQ8TE0BBKigV%2FEmb9T%2F%2BvYxmKcGOZ2iMe5dPC9GkmgGDc2Zaxjeh%2FsldIjhMywdgZAcaKgCk5zf6uys5EhO1zIKRBY225jOy9KHxCwpUeqx1NKsk0mMNO7tMsGOrAB3C2TMOREABZS%2BXnVNqLow5TsMAvKqicbqhHty5P31MiZi%2Fa8n0VSlCJAtFFwdfYyiqX60yfvu5%2FvoyOMJsH8aOK9VsLnxVNbyXQQyJryvsPax7hvKUthnXmhLSccACGHM27uvMMxcO%2BZvT0IjnaHpSxgceY0BJkP99A0ghuU730k8HwqtWOER9G2Yr2vFAqnqWmQjoU4MKKcfv2ZrSXGXKhszsyPoRY2YnUy0PvNwO4%3D&X-Amz-Signature=fceebec497e5db48e87654b55cfea1fbe98146741f8f1be39436fca02aa0300f&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Figure 4A

Figure 4B

Concordance of human papillomavirus (HPV) test results (among devices) and cytology (among laboratories)
| HPV test | Cytology | |||
|---|---|---|---|---|
| OPA (%) | kappa (95% CI) | OPAa (%) | kappa (95% CI) | |
| Qvintip group | 81.8 | 0.534 (0.349–0.718) | 74.8 | 0.471 (0.3029–0.641) |
| HerSwab group | 77.1 | 0.456 (0.2569–0.655) | 74.5 | 0.406 (0.2059–0.607) |
| Total | 79.6 | 0.495 (0.3599–0.632) | 74.6 | 0.444 (0.3159–0.574) |